Increased  	Increased  	 JJ	B-NP
bioavailability  	bioavailability  	 NN	I-NP
of  	of  	 IN	I-NP
hydrocortisone  	hydrocortisone  	 JJ	I-NP
dissolved  	dissolved  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
cream  	cream  	 NN	O
base  	base  	 NN	O
The  	The  	 DT	O
aim  	aim  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
compare  	compare  	 VB	O
vasoconstrictor  	vasoconstrictor  	 JJ	B-NP
activity  	activity  	 NN	I-NP
and 	and 	 CC	O
,  	,  	 ,	O
by  	by  	 IN	O
inference 	inference 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
effectiveness  	effectiveness  	 NN	I-NP
of  	of  	 IN	I-NP
hydrocortisone  	hydrocortisone  	 NN	I-NP
in  	in  	 IN	O
two  	two  	 CD	O
different  	different  	 JJ	O
formulations 	formulations 	 NNS	B-NP
:  	:  	 :	O
1 	1 	 CD	O
%  	%  	 NN	O
dissolved  	dissolved  	 VBN	O
hydrocortisone  	hydrocortisone  	 JJ	B-NP
cream  	cream  	 NN	I-NP
and  	and  	 CC	O
1 	1 	 CD	O
%  	%  	 NN	O
dispersed  	dispersed  	 VBD	O
hydrocortisone  	hydrocortisone  	 JJ	B-NP
cream 	cream 	 NN	I-NP
.  	.  	 .	O
Moisturising  	Moisturising  	 JJ	B-NP
capacity  	capacity  	 NN	I-NP
and  	and  	 CC	O
safety  	safety  	 NN	O
were  	were  	 VBD	O
also  	also  	 RB	O
determined 	determined 	 VBN	O
.  	.  	 .	O
Both  	Both  	 DT	O
topical  	topical  	 JJ	B-NP
preparations  	preparations  	 NNS	I-NP
were  	were  	 VBD	O
applied  	applied  	 VBN	O
without  	without  	 IN	O
occlusion  	occlusion  	 NN	B-NP
on  	on  	 IN	O
forearms  	forearms  	 VBG	O
twice  	twice  	 RB	O
daily  	daily  	 JJ	O
for  	for  	 IN	O
5  	5  	 CD	O
days 	days 	 NNS	O
.  	.  	 .	O
An  	An  	 DT	O
assessment  	assessment  	 NN	O
of  	of  	 IN	O
vasoconstriction  	vasoconstriction  	 NN	B-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
double-blinded  	double-blinded  	 JJ	O
manner  	manner  	 NN	B-NP
pretreatment  	pretreatment  	 NNS	I-NP
and  	and  	 CC	O
then  	then  	 RB	O
thrice  	thrice  	 JJ	O
daily  	daily  	 JJ	O
for  	for  	 IN	O
6  	6  	 CD	O
days  	days  	 NNS	O
and  	and  	 CC	O
once  	once  	 RB	O
7  	7  	 CD	O
days  	days  	 NNS	O
post-application 	post-application 	 JJ	B-NP
,  	,  	 ,	O
using  	using  	 VBG	O
an  	an  	 DT	O
objective  	objective  	 JJ	B-NP
rating  	rating  	 NN	I-NP
scale 	scale 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
the  	the  	 DT	O
dissolved  	dissolved  	 JJ	O
preparation  	preparation  	 NN	B-NP
only 	only 	 RB	O
,  	,  	 ,	O
moisturising  	moisturising  	 JJ	B-NP
capacity  	capacity  	 NN	I-NP
was  	was  	 VBD	O
determined  	determined  	 VBN	O
by  	by  	 IN	O
measurement  	measurement  	 NN	O
of  	of  	 IN	O
transepidermal  	transepidermal  	 JJ	B-NP
water  	water  	 NN	I-NP
loss  	loss  	 NN	I-NP
( 	( 	 -LRB-	O
TEWL 	TEWL 	 NNP	B-NP
)  	)  	 -RRB-	O
at  	at  	 IN	O
0 	0 	 CD	O
,  	,  	 ,	O
2 	2 	 CD	O
,  	,  	 ,	O
4 	4 	 CD	O
,  	,  	 ,	O
6  	6  	 CD	O
and  	and  	 CC	O
24  	24  	 CD	O
h 	h 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
also  	also  	 RB	O
by  	by  	 IN	O
the  	the  	 DT	O
measurement  	measurement  	 NN	O
of  	of  	 IN	O
water  	water  	 NN	O
content  	content  	 NN	O
at  	at  	 IN	O
0  	0  	 CD	O
and  	and  	 CC	O
24  	24  	 CD	O
h 	h 	 NNS	O
.  	.  	 .	O
Safety  	Safety  	 NNP	O
was  	was  	 VBD	O
assessed  	assessed  	 VBN	O
by  	by  	 IN	O
repeat  	repeat  	 NN	B-NP
insult  	insult  	 NN	I-NP
patch  	patch  	 NN	I-NP
tests  	tests  	 NNS	I-NP
( 	( 	 -LRB-	O
RIPT 	RIPT 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
all 	all 	 DT	O
,  	,  	 ,	O
10  	10  	 CD	O
volunteers  	volunteers  	 NNS	O
completed  	completed  	 VBD	O
the  	the  	 DT	O
vasoconstrictor  	vasoconstrictor  	 NN	B-NP
and  	and  	 CC	O
moisturising  	moisturising  	 JJ	B-NP
studies 	studies 	 NNS	I-NP
,  	,  	 ,	O
while  	while  	 IN	O
52  	52  	 CD	O
completed  	completed  	 VBD	O
the  	the  	 DT	O
RIPT 	RIPT 	 NNP	B-NP
.  	.  	 .	O
For  	For  	 IN	O
1 	1 	 CD	O
%  	%  	 NN	O
dissolved  	dissolved  	 VBN	O
hydrocortisone  	hydrocortisone  	 JJ	B-NP
cream  	cream  	 NN	I-NP
and  	and  	 CC	O
1 	1 	 CD	O
%  	%  	 NN	O
dispersed  	dispersed  	 VBD	O
hydrocortisone  	hydrocortisone  	 JJ	B-NP
cream 	cream 	 NN	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
,  	,  	 ,	O
areas  	areas  	 NNS	O
under  	under  	 IN	O
the  	the  	 DT	O
blanching  	blanching  	 JJ	O
curves  	curves  	 NN	O
were  	were  	 VBD	O
1240  	1240  	 CD	O
and  	and  	 CC	O
295 	295 	 CD	O
;  	;  	 :	O
total  	total  	 JJ	B-NP
scores  	scores  	 NNS	I-NP
were  	were  	 VBD	O
129.0  	129.0  	 CD	O
and  	and  	 CC	O
31.5 	31.5 	 CD	O
;  	;  	 :	O
summed  	summed  	 JJ	O
%  	%  	 NN	O
total  	total  	 JJ	B-NP
possible  	possible  	 JJ	I-NP
scores  	scores  	 NNS	I-NP
were  	were  	 VBD	O
161.3  	161.3  	 CD	O
and  	and  	 CC	O
39.4 	39.4 	 CD	O
;  	;  	 :	O
Tm 	Tm 	 NNP	B-NP
/ 	/ 	 CD	O
10  	10  	 CD	O
mean  	mean  	 JJ	O
values  	values  	 NNS	O
were  	were  	 VBD	O
3.47  	3.47  	 CD	O
and  	and  	 CC	O
1.64 	1.64 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
1 	1 	 CD	O
%  	%  	 NN	O
dissolved  	dissolved  	 VBN	O
hydrocortisone  	hydrocortisone  	 JJ	B-NP
cream  	cream  	 NN	I-NP
was  	was  	 VBD	O
found  	found  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
statistically  	statistically  	 RB	O
more  	more  	 RBR	O
potent  	potent  	 JJ	O
than  	than  	 IN	O
the  	the  	 DT	O
1 	1 	 CD	O
%  	%  	 NN	O
dispersed  	dispersed  	 VBD	O
hydrocortisone  	hydrocortisone  	 JJ	B-NP
cream 	cream 	 NN	I-NP
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
1 	1 	 CD	O
%  	%  	 NN	O
dissolved  	dissolved  	 VBN	O
hydrocortisone  	hydrocortisone  	 JJ	B-NP
cream  	cream  	 NN	I-NP
was  	was  	 VBD	O
found  	found  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
moisturising  	moisturising  	 VBN	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
no  	no  	 DT	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
No  	No  	 DT	O
adverse  	adverse  	 JJ	O
events  	events  	 NNS	O
were  	were  	 VBD	O
observed 	observed 	 VBN	O
.  	.  	 .	O
A  	A  	 DT	O
cream  	cream  	 NN	O
containing  	containing  	 VBG	O
1 	1 	 CD	O
%  	%  	 NN	O
dissolved  	dissolved  	 VBN	B-NP
hydrocortisone  	hydrocortisone  	 NN	I-NP
exhibits  	exhibits  	 VBZ	O
greater  	greater  	 JJR	O
vasoconstrictor  	vasoconstrictor  	 JJ	B-NP
activity  	activity  	 NN	I-NP
than  	than  	 IN	O
a  	a  	 DT	O
cream  	cream  	 NN	O
containing  	containing  	 VBG	O
1 	1 	 CD	O
%  	%  	 NN	O
dispersed  	dispersed  	 VBD	O
hydrocortisone 	hydrocortisone 	 VBN	O
.  	.  	 .	O
